Redbiotec is pleased to announce the appointment of Dr. Antonio Marchini, head of Laboratory of Oncolytic-Virus-Immuno-Therapeutics (LOVIT) at the Luxembourg Institute of Health and German Cancer Research Center (DKFZ), as a member of our Scientific Advisory Board. Antonio is an expert in the field of oncolytic viruses aiming at developing innovative anticancer agents. Redbiotec looks forward to this collaboration.
